SE434395B - Analogiforfarande for framstellning av karbostyrilderivat med terapeutisk verkan - Google Patents
Analogiforfarande for framstellning av karbostyrilderivat med terapeutisk verkanInfo
- Publication number
- SE434395B SE434395B SE7614539A SE7614539A SE434395B SE 434395 B SE434395 B SE 434395B SE 7614539 A SE7614539 A SE 7614539A SE 7614539 A SE7614539 A SE 7614539A SE 434395 B SE434395 B SE 434395B
- Authority
- SE
- Sweden
- Prior art keywords
- carbostyric
- derivatives
- preparing
- therapeutic effect
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C07D215/32—Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP51121423A JPS609713B2 (ja) | 1976-10-08 | 1976-10-08 | カルボスチリル誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7614539L SE7614539L (sv) | 1978-04-09 |
| SE434395B true SE434395B (sv) | 1984-07-23 |
Family
ID=14810767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7614539A SE434395B (sv) | 1976-10-08 | 1976-12-23 | Analogiforfarande for framstellning av karbostyrilderivat med terapeutisk verkan |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4223137A (xx) |
| JP (1) | JPS609713B2 (xx) |
| BE (1) | BE849794A (xx) |
| CA (1) | CA1074801A (xx) |
| CH (1) | CH618431A5 (xx) |
| DE (1) | DE2658544C2 (xx) |
| FR (1) | FR2378521A1 (xx) |
| GB (1) | GB1540628A (xx) |
| NL (1) | NL174041C (xx) |
| SE (1) | SE434395B (xx) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH17194A (en) * | 1980-03-06 | 1984-06-19 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives,and pharmaceutical composition containing the same |
| US4322425A (en) * | 1980-03-14 | 1982-03-30 | Otsuka Pharmaceutical Co., Ltd. | Compositions for treating glaucoma |
| FI77852C (fi) * | 1981-02-17 | 1989-05-10 | Otsuka Pharma Co Ltd | Foerfarande foer framstaellning av nya, saosom hjaertmediciner anvaendbara substituerade amid- och (maettad heterocykel)karbonylkarbostyrilderivat. |
| US4456757A (en) * | 1981-03-20 | 1984-06-26 | Asahi Kasei Kogyo Kabushiki Kaisha | Isoquinolinesulfonyl derivatives and process for the preparation thereof |
| EP0062001B1 (de) * | 1981-03-24 | 1987-05-27 | Ciba-Geigy Ag | Acyl-chinolinonderivate, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Präparate und ihre Verwendung |
| GB8334494D0 (en) * | 1983-12-24 | 1984-02-01 | Tanabe Seiyaku Co | Carbostyril derivatives |
| JPS60173736U (ja) * | 1984-04-25 | 1985-11-18 | 株式会社昭和製作所 | 緩衝器用サブタンク |
| JPS61191767A (ja) * | 1985-02-20 | 1986-08-26 | 辻本 夘太郎 | 植物張り家屋 |
| JPS62113672A (ja) * | 1985-11-12 | 1987-05-25 | 本田技研工業株式会社 | リヤクツシヨン用リザ−ブタンク |
| JPS6348401U (xx) * | 1986-09-17 | 1988-04-01 | ||
| US4687776A (en) * | 1986-10-24 | 1987-08-18 | Warner-Lambert Company | Drug stabilization |
| JPS63106132A (ja) * | 1986-10-24 | 1988-05-11 | Mazda Motor Corp | 車両のサスペンシヨン装置 |
| JPS6374545U (xx) * | 1986-10-31 | 1988-05-18 | ||
| JPH0517463Y2 (xx) * | 1987-07-21 | 1993-05-11 | ||
| JPS6417047U (xx) * | 1987-07-21 | 1989-01-27 | ||
| JPH0518510Y2 (xx) * | 1987-12-28 | 1993-05-17 | ||
| US4894219A (en) * | 1988-03-29 | 1990-01-16 | University Of Florida | Beta-agonist carbostyril derivatives, assay method and pharmacological composition |
| JPH026831U (xx) * | 1988-06-28 | 1990-01-17 | ||
| US6653323B2 (en) | 2001-11-13 | 2003-11-25 | Theravance, Inc. | Aryl aniline β2 adrenergic receptor agonists |
| US20030229058A1 (en) | 2001-11-13 | 2003-12-11 | Moran Edmund J. | Aryl aniline beta2 adrenergic receptor agonists |
| TWI249515B (en) | 2001-11-13 | 2006-02-21 | Theravance Inc | Aryl aniline beta2 adrenergic receptor agonists |
| US6747043B2 (en) | 2002-05-28 | 2004-06-08 | Theravance, Inc. | Alkoxy aryl β2 adrenergic receptor agonists |
| EP1565472A2 (en) * | 2002-11-27 | 2005-08-24 | Artesian Therapeutics, Inc. | Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure |
| TW200526547A (en) | 2003-09-22 | 2005-08-16 | Theravance Inc | Amino-substituted ethylamino β2 adrenergic receptor agonists |
| TW200531692A (en) | 2004-01-12 | 2005-10-01 | Theravance Inc | Aryl aniline derivatives as β2 adrenergic receptor agonists |
| FR2869893B1 (fr) * | 2004-05-06 | 2006-07-28 | Rhodia Chimie Sa | Nouveaux granules de phosphates de calcium de type hydroxyapatite, leur procede de preparation et leurs applications |
| WO2005110990A1 (de) * | 2004-05-13 | 2005-11-24 | Boehringer Ingelheim International Gmbh | Hydroxy-substituierte benzkondensierte heterozyklen als betaagonisten zur behandlung von atemwegserkrankungen |
| US7307076B2 (en) | 2004-05-13 | 2007-12-11 | Boehringer Ingelheim International Gmbh | Beta agonists for the treatment of respiratory diseases |
| WO2005121065A2 (en) | 2004-06-03 | 2005-12-22 | Theravance, Inc. | DIAMINE β2 ADRENERGIC RECEPTOR AGONISTS |
| EP1786762A2 (en) | 2004-09-10 | 2007-05-23 | Theravance, Inc. | Amidine substituted aryl aniline compounds |
| GB0624757D0 (en) * | 2006-12-12 | 2007-01-17 | Sosei R & D Ltd | Novel compounds |
| US9090618B2 (en) | 2012-12-27 | 2015-07-28 | Purdue Pharma L.P. | Substituted benzimidazole-type piperidine compounds and uses thereof |
| US9784726B2 (en) | 2013-01-08 | 2017-10-10 | Atrogi Ab | Screening method, a kit, a method of treatment and a compound for use in a method of treatment |
| GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB202205895D0 (en) | 2022-04-22 | 2022-06-08 | Atrogi Ab | New medical uses |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3975391A (en) * | 1973-12-26 | 1976-08-17 | Otsuka Pharmaceutical Company Limited | 5-[1-Hydroxy-2-(substituted-amino)]ethyl-8-hydroxy-3,4-dihydrocarbostyril derivatives |
| JPS539227B2 (xx) * | 1973-12-26 | 1978-04-04 | ||
| US4022784A (en) * | 1974-01-31 | 1977-05-10 | Otsuka Pharmaceutical Company Limited | 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-substituted-carbostyril and -3,4-dihydrocarbostyril derivatives |
| US4022776A (en) * | 1974-01-31 | 1977-05-10 | Otsuka Pharmaceutical Company Limited | 5-[1-Hydroxy-2-(substituted-amino)]ethyl-8-hydroxycarbostyril derivatives |
| US3994901A (en) * | 1974-06-13 | 1976-11-30 | Otsuka Pharmaceutical Company Limited | 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxy-3,4-dihydrocarbostyril derivatives |
| FI58329C (fi) * | 1974-11-08 | 1981-01-12 | Otsuka Pharma Co Ltd | Foerfarande foer framstaellning av i 8-staellning substituerade 5-(3'-alkylamino-2'-hydroxi)propoxi-3,4-dihydrokarbostyrilderivat |
-
1976
- 1976-10-08 JP JP51121423A patent/JPS609713B2/ja not_active Expired
- 1976-12-23 FR FR7638918A patent/FR2378521A1/fr active Granted
- 1976-12-23 GB GB53966/76A patent/GB1540628A/en not_active Expired
- 1976-12-23 CA CA268,691A patent/CA1074801A/en not_active Expired
- 1976-12-23 SE SE7614539A patent/SE434395B/xx not_active IP Right Cessation
- 1976-12-23 DE DE2658544A patent/DE2658544C2/de not_active Expired
- 1976-12-23 NL NLAANVRAGE7614329,A patent/NL174041C/xx not_active IP Right Cessation
- 1976-12-23 BE BE173581A patent/BE849794A/xx not_active IP Right Cessation
- 1976-12-27 CH CH1634376A patent/CH618431A5/fr not_active IP Right Cessation
-
1978
- 1978-08-10 US US05/932,572 patent/US4223137A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| SE7614539L (sv) | 1978-04-09 |
| AU2085576A (en) | 1978-04-06 |
| DE2658544C2 (de) | 1985-10-03 |
| US4223137A (en) | 1980-09-16 |
| FR2378521B1 (xx) | 1979-06-29 |
| CH618431A5 (xx) | 1980-07-31 |
| BE849794A (fr) | 1977-04-15 |
| NL174041B (nl) | 1983-11-16 |
| JPS609713B2 (ja) | 1985-03-12 |
| GB1540628A (en) | 1979-02-14 |
| NL174041C (nl) | 1984-04-16 |
| DE2658544A1 (de) | 1978-04-13 |
| CA1074801A (en) | 1980-04-01 |
| FR2378521A1 (fr) | 1978-08-25 |
| JPS5346983A (en) | 1978-04-27 |
| NL7614329A (nl) | 1978-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE434395B (sv) | Analogiforfarande for framstellning av karbostyrilderivat med terapeutisk verkan | |
| SE420921B (sv) | Analogiforfarande for framstellning av kinazolinderivat med terapeutisk verkan | |
| NO147243C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater | |
| SE7812268L (sv) | Fenylglycinderivat med terapeutisk verkan | |
| SE420314B (sv) | Analogiforfarande for framstellning av indolizinderivat | |
| SE423544B (sv) | Analogiforfarande for framstellning av imidazolderivat med antifungisk aktivitet | |
| SE438856B (sv) | Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat | |
| SE429338B (sv) | Forfarande for framstellning av substituerade 2-bensylpyrrolidiner med terapeutisk verkan | |
| SE7701379L (sv) | Forfarande for framstellning av bensendimetanolderivat med farmakologisk verkan | |
| SE437026B (sv) | Forfarande for framstellning av bensopyranderivat med antiallergisk verkan | |
| SE440907B (sv) | Forfarande for framstellning av imidazolderivat med farmaceutisk verkan | |
| SE411671B (sv) | Forfarande for framstellning av tripeptidderivat med terapeutisk verkan | |
| SE7804736L (sv) | Forfarande for framstellning av isoindolinderivat med terapeutisk verkan | |
| SE431336B (sv) | Analogiforfarande for framstellning av substituerade 8-azapurinderivat | |
| SE7514308L (sv) | Forfarande for framstellning av tyrosinderivat med terapeutisk verkan | |
| SE7703721L (sv) | Forfarande for framstellning av hexahydroprimidinforeningar med terapeutisk verkan | |
| SE7600343L (sv) | Forfarande for framstellning av ferrocenderivat med terapeutisk verkan | |
| SE7608538L (sv) | Forfarande for framstellning av substituerade fenylalkylaminoalkylbensenderivat med terapeutisk verkan | |
| SE425389B (sv) | Analogiforfarande for framstellning av vissa angivna oximetrar med antidepressiv verkan | |
| SE419083B (sv) | Analogiforfarande for framstellning av nikotinoylamino-triazinderivat | |
| SE7608115L (sv) | Forfarande for framstellning av kinoxalinderivat med terapeutisk verkan | |
| SE7805105L (sv) | Forfarande for framstellning av pyranokinolinderivat med terapeutisk verkan | |
| SE7712219L (sv) | Forfarande for framstellning av trans-5a-aryl-dekahydrobenzazpiner med terapeutisk verkan | |
| SE7713839L (sv) | Forfarande for framstellning av indanderivat med terapeutisk verkan | |
| SE7708521L (sv) | Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7614539-0 Effective date: 19910704 Format of ref document f/p: F |